Clinical Trial Update: Immunogenicity and Safety of Adacel Polio Vaccine [Phase 3]

View source ↗

Summary

Phase 3 trial results summarize the immunogenicity and safety of Adacel Polio Vaccine; the study is completed with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Adacel Polio Vaccine (Diphtheria, Tetanus, Acellular Pertussis and Inactivated Poliovirus Vaccine)

Snippet

Sponsor: Sanofi | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED | Results posted: 2012-11-26